Jeena Sikho Lifecare Limited — PPTs, 15-08-2025: Investor Presentation

Jeena Sikho Lifecare kicked off FY26 strong!

**Business Performance:** Q1 revenue hit ₹174.29 Cr, up a massive 74% YoY and 25% QoQ. Profitability soared with EBITDA at ₹78.79 Cr (220% YoY growth) and PAT at ₹51.31 Cr (218% YoY growth), pushing EBITDA margins to 45%. This growth was broad-based, fueled by a surge in patient volumes (IPD up 46% YoY, OPD up 68% YoY).

**Growth Strategy:** The company is strategically focusing on its higher-margin Private Panchkarma segment, aiming to moderate government panel business for better cash flow. Future priorities include scaling Panchkarma services and boosting Medicine & OTC sales.

**Recent Developments:** A key milestone was migrating to the NSE and BSE mainboard in August 2025, boosting market visibility. They also launched a new 'Pet Yakrit Pleeha Shuddhi Kit' with more products in the pipeline.

**Outlook:** Management is optimistic, citing expanded operational capacity (391 new beds added in Q1) and innovative offerings as drivers for sustained growth. These new beds are a solid foundation for FY26.